RBMY1A1 and hepatocellular carcinoma: Beyond the testis, RBMY has been shown to play a role in liver cancers where RBMY was expressed exclusively in the testis of 36% of cases with hepatocellular carcinoma (HCCs), in 67% cases with hepatoblastoma and also in a liver cancer cell line [123, 124].